Amy Ripka, CEO, Lucy Therapeutics
Amy Ripka, CEO, Lucy Therapeutics, explains how playing the violin professionally is great training for drug discovery work, why she rejects the command and control approach modeled by many biotech CEOs, and explains how climate science and ecology may contribute to a cure for Alzheimer’s